Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Tecan Systems Handle High Throughput Prediction of Cancer Recurrence

Published: Wednesday, August 08, 2007
Last Updated: Thursday, August 09, 2007
Bookmark and Share
Genomic Health Inc researchers have chosen Tecan’s liquid handling workstations to automate the multi-gene expression assay that predicts recurrence of cancer.

Researchers at the life sciences company Genomic Health Inc., California, have chosen Tecan’s liquid handling workstations to automate the development of their multi-gene expression assay that predicts the risk of recurrence of cancer and the likelihood of chemotherapy benefit in a large portion of early-stage breast cancer patients.

Jay Snable, Director of Process Automation, explained: “We needed automated systems for our ongoing assay development and we chose Tecan for its highly flexible technology. Tecan provided the best solutions for handling all the different formats we need, from single tubes through to 384-well microplates, in a highly integrated system with quality controls all the way.”

Snable continued, “We have developed a gene panel to quantify the likelihood of breast cancer recurrence, and we are currently looking at 761 genes in an initial screen to create a gene profile for an assay to test for risk of recurrence of another cancer type - this is where the Tecan technology will prove especially useful for the high throughput we need to achieve.”

Based on Tecan’s Freedom EVO® 200 and Genesis™ platforms, all assay steps after RNA extraction are automated, from RNA quantification and quality control, reverse transcription and quantitative PCR assay assembly. The workstations are also equipped with a PosID™ System for automated barcode scanning and identification to track individual samples through all the assay steps.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Robotics and Proteomics: A Promising Partnership for Biomarker Discovery
CLIPP scientists use two of Tecan’s Freedom EVO® platforms to automate sample preparation for a biomarker discovery project.
Thursday, July 23, 2009
Automation Improves Tobacco Research
ATC utilizes Quantitative PCR techniques to assay transgenic plant cells, and Tecan’s Freedom EVO® 100 to automate pipetting tasks.
Thursday, April 09, 2009
Tecan Platforms Improve Microarray Throughput and Research Quality in South Africa
Researchers have established a high throughput biological research platform with a number of automated microarray processing systems from Tecan.
Monday, March 10, 2008
Tecan to Display Automation Solutions at AABB Annual Meeting and TXPO 2005
Tecan is exhibiting liquid handling workstations, microplate reader and a strip-washer.
Monday, October 17, 2005
Tecan to reduce workforce

Monday, July 29, 2002
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Uncovering Water Bear Resilience
A protein identified in water bears can protect DNA of human cells from lethal doses of radiation damage.
Smart Material Hunts Cancers
Team has created smart material that locates and images cancer or tumour sites in tissue.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
Stem Cells Growing 3D Lung-in-a-Dish
Researchers have created 3D lung-like tissue from lung-derived stem cells. The tissue can be used to study lung diseases.
The Genetics of Blood Pressure
Researchers have identifed areas of the genome associated with blood-pressure including 17 previously unknown loci.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!